Search For "covaxin"
WHO's advisory group to meet on Oct 26 to consider Covaxin's emerg
Updated : 7 hours, 4 min ago IST
Geneva [Switzerland], October 17 (ANI): Dr Soumya Swaminathan, World Health Organisation (WHO) chief scientist on Sunday informed that WHO's technical advisory group will meet on October 26 to consider emergency use listing (EUL) for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covax
Read More
India to procure over 30 crore COVID-19 vaccine doses per month by
Updated : 1 day, 14 hours ago IST
New Delhi [India], October 16 (ANI): India will have a vaccine capacity of 28 crore doses this month, which includes 22 crore Serum Institute of India's Covishield and 6 crore doses of Bharat Biotech Biotech's Covaxin and production of 60 lakh Zydus Cadila's ZyCoV-D doses are also ready,
Read More
I'm sure approval of Covaxin from WHO will come at soonest possibl
Updated : 3 days ago IST
Bhubaneswar (Odisha) [India], October 15 (ANI): Foreign Secretary Harsh Vardhan Shringla on Thursday expressed hope that the World Health Organisation (WHO) will soon give approval to Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin.
Read More
Covaxin's approval for children aged 2-18 yrs under experts' opini
Updated : 3 days, 8 hours ago IST
New Delhi [India], October 14 (ANI): The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday.
Read More
India exports 10 crore Covid-19 jabs each to Bangladesh, Nepal, My
Updated : 3 days, 10 hours ago IST
New Delhi [India], October 14 (ANI): After the resumption of export of COVID-19 vaccines in October, India has exported 10 crore vaccines each to Nepal, Myanmar, Iran and Bangladesh under Vaccine Maitri, said the government sources.
Read More
60 lakh vaccine doses of ZyCoV-D are ready after production in Oct
Updated : 4 days, 13 hours ago IST
New Delhi [India], October 13 (ANI): As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.
Read More
Awaiting regulatory approval for rolling out Covaxin for children
Updated : 5 days, 8 hours ago IST
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesday
Read More
Approval to Covaxin for children aged between 2-18 years awaited a
Updated : 5 days, 12 hours ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More
COVID-19: Subject Expert Committee gave recommendation to DCGI to
Updated : 5 days, 15 hours ago IST
New Delhi [India], October 12 (ANI): Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine Covaxin for the beneficiaries aged between 2-18 years, the official sources said.
Read More
Covaxin trials on children show similar results as on adults, says
Updated : 6 days, 5 hours ago IST
New Delhi [India], October 11 (ANI): As India's largest COVID-19 vaccination drive is underway, an AIIMS professor has claimed that the latest trials show that the safety and immunogenicity of India's indigenous COVID-19 vaccine--Covaxin--are almost the same in children, as adults above 1
Read More
India-UK travel restrictions row to end soon, hopes MEA
Updated : 1 week, 3 days ago IST
New Delhi [India], October 7 (ANI): The Ministry of External Affairs on Thursday said that there can be an early solution to the India-UK travel restrictions row.
Read More
WHO decision on Covaxin nod extended to next week
Updated : 1 week, 5 days ago IST
Geneva [Switzerland], October 5 (ANI): World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin to next week.
Read More